These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 834123)

  • 21. Gender-based mortality follow-up from the Program on the Surgical Control of the Hyperlipidemias (POSCH) and meta-analysis of lipid intervention trials. Women in POSCH and other lipid trials.
    Buchwald H; Campos CT; Boen JR; Nguyen P; Williams SE; Lau J; Chalmers TC
    Ann Surg; 1996 Oct; 224(4):486-98; discussion 498-500. PubMed ID: 8857853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial ileal bypass in the treatment of hypercholesterolemia.
    Buchwald H; Fitch LL; Campos CT
    J Fam Pract; 1992 Jul; 35(1):69-76. PubMed ID: 1301017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial ileal bypass in type II familial hypercholesterolemia. Eleven-year experience at the Montreal Heart institute.
    Vaislic CD; Grondin PR; Bourassa MG; Campeau L
    Am Surg; 1984 Mar; 50(3):165-8. PubMed ID: 6367576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial ileal bypass for hypercholesterolemia and atherosclerosis.
    Buchwald H; Varco RL
    Surg Gynecol Obstet; 1967 Jun; 124(6):1231-8. PubMed ID: 6024201
    [No Abstract]   [Full Text] [Related]  

  • 25. Ileal bypass in hypercholesterolemia associated with coronary heart disease.
    Swan DM; McGowan JM
    Am J Surg; 1968 Jul; 116(1):22-7. PubMed ID: 5652356
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of ileal bypass on dietary-induced artherosclerosis in the rabbit.
    Okuboye JA; Ferguson CC; Wyatt JP
    Can J Surg; 1968 Jan; 11(1):69-77. PubMed ID: 5759588
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of partial ileal shunting in hypercholesteremia and arteriosclerosis].
    Khil'kin AM; Zemlianikov VV
    Kardiologiia; 1976 Apr; 16(4):141-8. PubMed ID: 828946
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of risk factor management in progression and regression of coronary and femoral artery atherosclerosis.
    Glueck CJ
    Am J Cardiol; 1986 May; 57(14):35G-41G. PubMed ID: 3521250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease].
    Jost S; Lichtlen PR
    Z Kardiol; 1995 Aug; 84(8):577-95. PubMed ID: 7571764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ileal bypass in the prevention and therapy of experimentally induced hypercholesteremia and atherosclerosis].
    Saba V; Dettori G; Farris A; Alò F; Bacciu PP; Perisi P; Bianca T
    Chir Patol Sper; 1974 Apr; 22(2):61-88. PubMed ID: 4434787
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of lipid lowering therapy in patients with peripheral arterial occlusive disease].
    Wittlinger T; Kröger K
    Herz; 2004 Feb; 29(1):12-6. PubMed ID: 14968337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Partial ileal bypass in the treatment of hyperlipidemia].
    Suchý T; Lesko M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1990; 33(2):115-21. PubMed ID: 2263904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The surgical treatment of atherosclerosis with ileal exclusion. Experimental presuppositions and possibilities of clinical application].
    Cagetti M; Dragone G
    Policlinico Chir; 1971; 78(1):12-28. PubMed ID: 5580513
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term effects of ileal bypass on lipoproteins in patients with familial hypercholesterolemia.
    Koivisto P; Miettinen TA
    Circulation; 1984 Aug; 70(2):290-6. PubMed ID: 6733883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is regression of atherosclerosis possible?].
    Thomas D; Richard JL; Emmerich J; Bruckert E; Delahaye F
    Arch Mal Coeur Vaiss; 1992 Oct; 85 Spec No 3():47-57. PubMed ID: 1296545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of familial hypercholesterolaemia by partial ileal bypass.
    Russell D; Fritz V; Mieny CJ; Mendelsohn D; Joffe BI; Seftel HC
    S Afr Med J; 1979 Feb; 55(7):237-40. PubMed ID: 441862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Partial ileal bypass for familial hypercholesterolemia].
    Basson JJ; Nel CJ; De Wet JI; Monk EJ
    S Afr J Surg; 1992 Dec; 30(4):145-7. PubMed ID: 1295095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarction.
    Matts JP; Buchwald H; Fitch LL; Campos CT; Varco RL; Campbell GS; Pearce MB; Yellin AE; Smink RD; Sawin HS
    J Clin Epidemiol; 1995 Mar; 48(3):389-405. PubMed ID: 7897460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of ileal bypass versus administration of clofibrate on experimental hypercholesterolemia and atherosclerosis in monkeys.
    Younger RK; Curtis JJ; Butts WH; Scott HW
    South Med J; 1976 Sep; 69(9):1141-2, 1145. PubMed ID: 823644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastric obesity surgery combined with partial ileal bypass for hypercholesterolemia.
    Buchwald H; Schone JL
    Obes Surg; 1997 Aug; 7(4):313-6. PubMed ID: 9730516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.